Journal
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
Volume 474, Issue 4, Pages 421-434Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s00424-022-02666-y
Keywords
Nociception; Neuropathic pain; Ca(V)3; 2; Ca(V)2; 2; Expression; Modulation
Categories
Funding
- Grant agency of Ministry of Education, Science, Research, and Sport of Slovak Republic VEGA grant [2/0143/19]
Ask authors/readers for more resources
This article reviews current knowledge about the expression and distribution of calcium channels in the nociceptive pathway, their regulation and gating during pain pathology, and their suitability as targets for pharmacological therapy.
Noxious stimuli like cold, heat, pH change, tissue damage, and inflammation depolarize a membrane of peripheral endings of specialized nociceptive neurons which eventually results in the generation of an action potential. The electrical signal is carried along a long axon of nociceptive neurons from peripheral organs to soma located in dorsal root ganglions and further to the dorsal horn of the spinal cord where it is transmitted through a chemical synapse and is carried through the spinal thalamic tract into the brain. Two subtypes of voltage-activated calcium play a major role in signal transmission: a low voltage-activated Ca(V)3.2 channel and a high voltage-activated Ca(V)2.2 channel. The Ca(V)3.2 channel contributes mainly to the signal conductance along nociceptive neurons while the principal role of the Ca(V)2.2 channel is in the synaptic transmission at the dorsal horn. Both channels contribute to the signal initiation at peripheral nerve endings. This review summarizes current knowledge about the expression and distribution of these channels in a nociceptive pathway, the regulation of their expression and gating during pain pathology, and their suitability as targets for pharmacological therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available